Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01097850
Other study ID # NU 09D1
Secondary ID
Status Withdrawn
Phase Phase 2
First received March 31, 2010
Last updated December 11, 2014
Start date March 2010
Est. completion date January 2012

Study information

Verified date December 2014
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug AdministrationUnited States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether henna paste is effective in the treatment of hand-foot skin syndrome, induced by the drugs Capecitabine and pegylated liposomal doxorubicin.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 2012
Est. primary completion date January 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients receiving capecitabine and/or pegylated liposomal doxorubicin as monotherapy or in combination with other agents

- New diagnosis of active hand-foot skin reaction (on bilateral hands and/or bilateral feet) of 1-3 toxicity as defined by the NCI-CTCAE version 4.0 grading scale with onset of symptoms within the last thirty days

- Patients must be 18 years or older

- Patients must provide written informed consent to participate in the study

Exclusion Criteria:

- Patients with pre-existing dermatological condition affecting the hands or feet that may limit the interpretation of results

- Known allergy to natural henna

- Patients with a previous history of HFS

- History of G6PD deficiency as determined by screening bloodwork

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
henna paste
Henna paste will be applied to either the left hand/foot or right hand/foot, along with CeraVe moisturizer to both hands/feet

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Northwestern University

Outcome

Type Measure Description Time frame Safety issue
Primary • To compare the severity of HFS in subjects receiving topical natural henna paste treatment along with using CeraVe™ moisturizing cream concurrently on the treatment side and using only CeraVe™ moisturizing cream on the control side. 3 weeks Yes
Secondary To examine quality of life, comparing natural henna treatment versus CeraVe™ alone, using the Skindex-16 questionnaire 3 weeks No